Aditxt (NASDAQ:ADTX – Get Free Report) announced its earnings results on Tuesday. The company reported $11,687.53 earnings per share for the quarter, FiscalAI reports. Aditxt had a negative net margin of 684,001.00% and a negative return on equity of 461.78%.
Aditxt Price Performance
Shares of ADTX stock opened at $0.90 on Thursday. Aditxt has a 1 year low of $0.76 and a 1 year high of $5,214.72. The firm has a market capitalization of $81,890.90, a price-to-earnings ratio of 0.00 and a beta of 1.53. The business has a fifty day moving average of $3.97 and a 200 day moving average of $143.44.
Wall Street Analyst Weigh In
Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Aditxt in a research note on Wednesday, January 21st. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock presently has an average rating of “Sell”.
About Aditxt
Aditxt, Inc is a clinical-stage biotechnology company focused on the development and commercialization of natural antimicrobial peptides and microbiome-based detection technologies. Leveraging proprietary peptide libraries, the company aims to provide novel solutions for infection prevention and control across healthcare, food safety, animal health and agricultural markets. Aditxt’s approach centers on harnessing peptides that can disrupt microbial cell membranes without promoting resistance, addressing a growing need for alternatives to traditional antibiotics and chemical disinfectants.
The company’s product offerings include contract-based microbial detection and identification services, designed to help hospitals, food processors and other regulated industries monitor contamination levels and validate hygiene protocols.
Featured Articles
Receive News & Ratings for Aditxt Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aditxt and related companies with MarketBeat.com's FREE daily email newsletter.
